Remove 2013 Remove Competition Remove Leads
article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

This is going to lead to a lot of health problems and associated costs. Increased provider consolidation has decreased individual market competition, in which lower prices, improved productivity, and innovation can occur. 1ne: A new analysis predicts that by 2030, 48.9% of adults in the United States will be obese, and 24.2%

article thumbnail

149 Eye-Opening Sales Statistics to Consider in 2022 (By Category)

Spotio

Outside Sales Reps Now Spend 89% More Time Selling Remotely Than in 2013. Sales Prospecting Statistics The way companies prospect for leads is changing. HubSpot] 9 in 10 companies use 2+ lead enrichment tools to learn more about prospects. With so much potential, comes a lot of competition. of the sales force.

Sales 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma R&D productivity dips, but efficiency gains give hope

Clarivate

Figure 1 illustrates the trend in the number of NMEs first launched onto the world market between 2013 and 2022. In fact, the number of NMEs has grown by 65% between 2013 and 2022. Looking at NMEs launched globally in 2022 paints a gloomy picture at first sight, with a 28% drop from 2021 to 2022.

Pharma 52
article thumbnail

Kyowa Kirin drops Nourianz follow-up KW-6356 for Parkinson’s

pharmaphorum

.” KW-6356 is a follow-up to Kyowa Kirin’s first-generation adenosine A2 antagonist Nourianz/Nouriast (istradefylline), which finally claimed FDA approval in 2019 as an add-on to levodopa in Parkinson’s after more than two decades of R&D and has been available in Japan since 2013. billion yen (around $68 million).

article thumbnail

Streamlining bioprocessing for gene therapy

European Pharmaceutical Review

Innovations in biotechnology, such as genetic engineering, enable the development of optimised microbial strains and production processes, leading to increased yields, reduced production costs and enhanced scalability. He was named Head of Process Development in 2013, then promoted to Chief Scientific Officer (CSO) in 2020.

article thumbnail

THEPM360TRAILBLAZER AWARD WINNER – Lifetime Achievement Award – Adam Schechter, CEO and Chairman, Labcorp

PM360

Prior to that, he was named Lead Independent Director in 2019 after serving as a director of the company since 2013. Adam is an ethical leader who leads his business to serve the needs of patients and advance healthcare globally. This honor truly commended a lifetime of leadership.

Ethics 59
article thumbnail

Developments In B2B Healthcare Marketing

Scott’s Directories

The healthcare industry is pretty competitive, recording massive growth yearly. With modern digital marketing tools, healthcare marketers can focus on finding quality leads without expensive expos. Here are some developments in B2B healthcare marketing that can help stay competitive in the healthcare industry.